Diabetes
PhD candidate Saliba receives translational science outstanding trainee award
April 20, 2022Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu CHICAGO (April 20, 2022) — Afaf Saliba, MSc, a student in the PhD in Integrated Biomedical Sciences degree program at The University of Texas Health Science Center at San Antonio, today received a Translational Science Award from the Association for Clinical and Translational Science (ACTS). ACTS, a non-profit membership association […]
Boosting liver mRNAs curbs appetite, body weight in obese mice
April 5, 2022Novel approach identified to tackle metabolic diseases. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (April 5, 2022) — In a breakthrough discovery, scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today reported that inhibiting a liver enzyme in obese mice decreased the rodents’ appetite, increased energy […]
Department of Biochemistry and Structural Biology assistant professor earns UT System Rising STARs award to further metabolic disease research
April 1, 2022Kevin Koronowski, PhD, assistant professor in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine and the Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, received a UT System Rising STARs (Science and Technology Acquisition and Retention) award in […]
Groundbreaking research offers hope to unlock the keys to childhood type 2 diabetes
February 16, 2022Yidong Bai, PhD, professor, Department of Cell Systems and Anatomy, was recently awarded a $1.2 million grant from the Baptist Health Foundation of San Antonio, whose mission is focused on improving community health. The funds will be used to investigate the role of mitochondrial regulation and dysfunction in childhood type 2 diabetes, which is particularly […]
Trailblazing diabetes researcher receives 2022 Luminary in Cardiometabolic Medicine Award
January 28, 2022Noted diabetes researcher Ralph DeFronzo, MD, has received the 2022 Luminary in Cardiometabolic Medicine award from the Metabolic Institute of America. Dr. DeFronzo is chief of diabetes at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and deputy director of the University Health System’s Texas Diabetes Institute. As the […]
Healio: Two diabetes drug classes can increase, maintain beta-cell function
December 3, 2021Dr. Ralph DeFronzo, Diabetes, is quoted in this Healio article. Read story